Trusting science is good, but it could put you at risk for being duped by false science, or “pseudoscience,” if you let your guard down, researchers warn. Investigators found that people who trust science are more likely to believe and share false claims that contain scientific references than those who don’t trust science. “We conclude… read on > read on >
Black men in the United States have higher rates of prostate cancer than white men, yet they were far less likely to have surgery for their cancer during the first wave of the COVID-19 pandemic, a new study finds. Researchers analyzed data from a Pennsylvania urologic database to compare prostate removal (prostatectomy) rates among Black… read on > read on >
Determined to Ignore the Warning Signs, He’s Put That Same Determination Into Heart Attack Recovery read on >
Young people aren’t immune from severe COVID-19, and a new study warns that some are more at risk than others. Folks under 45 have more than triple the risk for severe COVID-19 if they have cancer or heart disease, or blood, neurologic or endocrine disorders, according to Mayo Clinic researchers. “One of the surprising findings… read on > read on >
Bullying remains a threat to American teens, and a new study reveals which kids may be at highest risk. Race-based bullying takes a heavy toll on teens, the research found, but minority kids who are picked on for other reasons — whether gender, sexual orientation, religion, disability or immigration status — suffer a double whammy.… read on > read on >
Serious “long COVID” symptoms could qualify as a disability and make patients eligible for federal assistance, President Joe Biden said Monday. Some recovered COVID-19 patients have lasting problems such as fatigue, brain fog, joint pain, fever and double vision, which “can sometimes rise to the level of a disability,” Biden said during a White House… read on > read on >
Two long used types of blood pressure drugs are equally effective, but the less popular one seems to have fewer side effects, according to a large “real-world” study. The two classes of medication are both recommended as “first-line” treatments for high blood pressure: angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs). ACE inhibitors have… read on > read on >
While efforts to develop Alzheimer’s medications have so far borne little fruit, new research highlights the therapeutic promise of two non-drug tools: light and sound. According to a pair of small new studies, exposing Alzheimer’s patients to an hour a day of carefully modulated light and/or sound appears, over time, to slow down the telltale… read on > read on >
(HealthDay News) – If you’re a rare case of someone who had an allergic reaction to your first dose of the Pfizer or Moderna COVID-19 vaccines, here’s reassuring news: It’s safe for you to get that necessary second dose. That’s according to a team of allergists working at several U.S. hospitals. They examined second-dose vaccine… read on > read on >
Watch videos on TikTok and you’re likely to see plenty of positive portrayals of vaping, a new study shows. And that’s a problem, according to researchers, who call for tighter regulation of the platform popular with kids and teens. “Viewing other young people, friends, acquaintances or influencers vaping in fun and entertaining contexts, is likely… read on > read on >
